CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Clinical trials for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS LUPUS ERYTHEMATOSUS (CLE) trials appear
Sign up with your email to follow new studies for CUTANEOUS LUPUS ERYTHEMATOSUS (CLE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug VENT-03 shows promise for lupus skin lesions in early trial
Disease control Recruiting nowThis study tests a new drug called VENT-03 for people with lupus that affects the skin (cutaneous lupus). The goal is to see if it can reduce skin symptoms and is safe. About 24 adults will take either VENT-03 or a placebo for 4 weeks, then everyone gets VENT-03 for 8 more weeks.…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Phase: PHASE2 • Sponsor: Ventus Therapeutics U.S., Inc. • Aim: Disease control
Last updated Jun 14, 2026 10:53 UTC
-
New drug S-4321 aims to tame overactive immune system
Disease control Recruiting nowThis early-stage study tests a new drug called S-4321 in 24 adults with autoimmune diseases like rheumatoid arthritis, psoriasis, lupus, or eczema. The goal is to check safety and how the drug affects the body. Participants receive multiple doses and are monitored for side effect…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Phase: PHASE1 • Sponsor: Seismic Therapeutic AU Pty Ltd • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC
-
New pill aims to calm lupus skin flares in major trial
Disease control Recruiting nowThis study tests an experimental pill called enpatoran for people with lupus who have active skin rashes. About 202 participants will receive either the drug or a placebo for 24 weeks, while continuing their usual treatments. The goal is to see if enpatoran can significantly redu…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Phase: PHASE3 • Sponsor: EMD Serono Research & Development Institute, Inc. • Aim: Disease control
Last updated Jun 05, 2026 12:06 UTC
-
Lupus skin study seeks 700 volunteers to track disease impact
Knowledge-focused Recruiting nowThis study aims to learn more about cutaneous lupus, a skin condition caused by lupus. Researchers will track 700 adults to see how often it occurs and how serious it can be. No treatments are tested—only information is collected to better understand the disease.
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:07 UTC
-
Lupus patients can now help research without leaving home
Knowledge-focused Recruiting nowThis study is a registry for people with lupus to share information about their health and quality of life through online surveys. It aims to help researchers better understand lupus and improve care. Anyone with lupus who is 18 or older (or a parent of a child with lupus) can jo…
Matched conditions: CUTANEOUS LUPUS ERYTHEMATOSUS (CLE)
Sponsor: Lupus Foundation of America • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:05 UTC